Investigation of the mechanism of action of 3-(4-bromophenyl)-5- acyloxymethyl-2,5-dihydrofuran-2-one against Candida albicans by flow cytometry

Bioorganic and Medicinal Chemistry Letters

Volumn 16, Issue 9, 2006, Pages 2492-2495

  Vale Silva, Luís A ^a   Buchta, Vladimír ^a,b   Vokurková, Doris ^b   Pour, Milan ^a  

^a Charles University in Prague Faculty of Pharmacy   (Czech Republic)

^b UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

Antifungal; Candida; Flow cytometry; Furanones; Incrustoporine; Mechanism of action

Indexed keywords

2 CHLORO 4 [2,3 DIHYDRO 3 METHYL(BENZO 1,3 THIAZOL 2 YL)METHYLIDENE] 1 PHENYLQUINOLINIUM IODIDE; 3 (4 BROMOPHENYL) 5 ACYLOXYMETHYL 2,5 DIHYDROFURAN 2 ONE; 3 (4 BROMOPHENYL) 5 HYDROXYMETHYL 2,5 DIHYDROFURAN 2 ONE; AMPHOTERICIN B; ANTIFUNGAL AGENT; BIS(1,3 DIBUTYLBARBITURIC ACID)TRIMETHINE OXONOL; FLUCONAZOLE; FLUORESCENT DYE; INCRUSTOPORINE DERIVATIVE; PROPIDIUM IODIDE; UNCLASSIFIED DRUG;

ARTICLE; CANDIDA ALBICANS; CELL DAMAGE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; DRUG SENSITIVITY; FLOW CYTOMETRY; FUNGICIDAL ACTIVITY; FUNGUS GROWTH; GROWTH INHIBITION; NONHUMAN;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; FLOW CYTOMETRY; FURANS; MICROBIAL SENSITIVITY TESTS; STRUCTURE-ACTIVITY RELATIONSHIP;

CANDIDA; CANDIDA ALBICANS; FUNGI;

EID: 33644972475     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2006.01.094     Document Type: Article

References (19)

1. T.C. White, K.A. Marr, and R.A. Bowden Clin. Microbiol. Rev. 11 1998 382
2. D.W. Denning, C.C. Kibler, and R.A. Barnes Lancet Infect. Dis. 3 2003 230
3. S. Zapf, T. Anke, and O. Sterner Acta Chem. Scand. 49 1995 233
4. M. Pour, M. Špulák, V. Balšánek, J. Kuneš, V. Buchta, and K. Waisser Bioorg. Med. Chem. Lett. 10 2000 1893
5. M. Pour, M. Špulák, V. Buchta, P. Kubanová, M. Vopršalová, V. Wsól, H. Fáková, P. Koudelka, H. Pourová, and R. Schiller J. Med. Chem. 44 2001 2701
6. M. Pour, M. Špulák, V. Balšánek, J. Kuneš, P. Kubanová, and V. Buchta Bioorg. Med. Chem. 11 2003 2843
7. V. Buchta, M. Pour, P. Kubanová, L. Silva, I. Votruba, M. Vopršálová, R. Schiller, H. Fáková, and M. Špulák Antimicrob. Agents Chemother. 48 2004 873
8. H.M. Davey, and D.B. Kell Microbiol. Rev. 60 1996 641
9. D. Deere, J. Shen, G. Vesey, P. Bell, P. Bissinger, and D. Veal Yeast 14 1998 147
10. H.M. Shapiro Methods 21 2000 271
11. P.J. Millard, B.L. Roth, H.P. Thi, S.T. Yue, and R.P. Haugland Appl. Environ. Microbiol. 63 1997 2897
12. 5.
13. J. Kirschbaum, and S.G. Kahn J. Pharm. Sci. 56 1967 278
14. 15 The incubation program was set for 24 h at 35°C with turbidimetric readings at intervals of 1 h. The reading wavelength was 540 nm and shaking of the plate was set for a period of 30 s at medium speed before each turbidimetric reading.
15. J. Van Eldere, L. Joosten, A. Verhaeghe, and I. Surmont J. Clin. Microbiol. 34 1996 842
16. 4(3), corresponding to waiting times of around 10 min at room temperature. For FUN-1, the readings were done after a previous incubation of the suspensions with the dye for 20 min at 35°C away from incident light.
17. 4(3), dotplot cytograms of FL3 versus FL1 channel fluorescence were analyzed in addition to the referred separate histogram analysis.
18. F.C. Odds, A.J.P. Brown, and N.A.R. Gow Trends Microbiol. 11 2003 272
19. National Committee for Clinical Laboratory Standards. NCCLS document M27-A2. Wayne, PA, USA, 2002.